Charts Regen BioPharma, Inc.

Equities

Delayed OTC Markets Other stock markets 10:10:55 2024-05-17 EDT			5-day change	1st Jan Change
0.7 ^USD	+0.72%		+3.70%	-26.32%

04-24	Regen BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
02-09	Regen Biopharma, Inc. Files Provisional Patent Application for Accelerating Hematopoietic Reconstitution After an Insult or Chronic Pathology by Administration of Stem Cell Derived Endothelial Progenitor Cells or Endothelial Cells	CI

ProRealTime Chart